반응 #155999

ord-34e44206e1d9499f901298242fa9e8ba

반응 방정식

c1ccc(-c2noc(N3CCC(NC4CC4)CC3)n2)cc1
cyclopropyl-[1-(3-phenyl-[1,2,4]oxadiazol-5-yl)-piperidin-4-yl]-amine
CN(C)C(On1nnc2ccccc21)=[N+](C)C.F[B-](F)(F)F
2-(1H-Benzotriazol-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate
CCN(C(C)C)C(C)C
ethyldiisopropylamine
O=C(O)c1ccc(-c2ccncc2)cc1
4-pyridin-4-yl-benzoic acid
O=C(c1ccc(-c2ccncc2)cc1)N(C1CC1)C1CCN(c2nc(-c3ccccc3)no2)CC1
N-Cyclopropyl-N-[1-(3-phenyl-[1,2,4]oxadiazol-5-yl)-piperidin-4-yl]-4-pyridin-4-yl-benzamide

반응 조건

상세 조건
See reaction.notes.procedure_details.

후처리

  1. 1
    workup.STIRRINGThe resulting mixture is stirred at 60° C. for 5 h
  2. 2
    농축concentrated in vacuo
  3. 3
    기타The crude product is purified by HPLC (H2O/MeOH/TFA)

실험 절차

2-(1H-Benzotriazol-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate (75 mg) and ethyldiisopropylamine (74 μL) are added to a solution of 4-pyridin-4-yl-benzoic acid (42 mg) in N,N-dimethylformamide (5 mL) at room temperature. The solution is stirred for 10 min prior to the addition of cyclopropyl-[1-(3-phenyl-[1,2,4]oxadiazol-5-yl)-piperidin-4-yl]-amine (60 mg). The resulting mixture is stirred at 60° C. for 5 h, cooled to room temperature and concentrated in vacuo. The crude product is purified by HPLC (H2O/MeOH/TFA). LC (method 6): tR=1.44 min; Mass spectrum (ESI+): m/z=466 [M+H]+.

출처

DOI: 10.6084/m9.figshare.5104873.v1특허: US08822471B2uspto-grants-2014_09